Peter G. Linde
2021
In 2021, Peter G. Linde earned a total compensation of $2.3M as Chief Medical Officer former at Morphic Holding, a 19% decrease compared to previous year.
Compensation breakdown
| Option Awards | $1,815,235 |
|---|---|
| Salary | $450,200 |
| Other | $8,700 |
| Total | $2,274,135 |
Linde received $1.8M in option awards, accounting for 80% of the total pay in 2021.
Linde also received $450.2K in salary and $8.7K in other compensation.
Rankings
In 2021, Peter G. Linde's compensation ranked 5,530th out of 12,415 executives tracked by ExecPay. In other words, Linde earned more than 55.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,530 out of 12,415 | 56th |
Division Manufacturing | 2,341 out of 5,505 | 58th |
Major group Chemicals And Allied Products | 1,018 out of 2,375 | 57th |
Industry group Drugs | 907 out of 2,096 | 57th |
Industry Pharmaceutical Preparations | 652 out of 1,546 | 58th |
Source: SEC filing on April 29, 2022.
Linde's colleagues
We found four more compensation records of executives who worked with Peter G. Linde at Morphic Holding in 2021.